Cubist Pharmaceuticals commences a $600M note offering

|By:, SA News Editor

Cubist Pharmaceuticals (CBST) says it will commence a $600M offering in convertible senior unsecured notes.

The notes are expected to be issued in two $300M series, with one series maturing in 2018 and the other series maturing in 2020.

The company also expects to grant the initial purchasers an option to purchase up to an additional $50M of each series.